Alternative splicing in the NF-kappaB signaling pathway.

[1]  N. Rice,et al.  A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon. , 1989, Oncogene.

[2]  J. Ihle,et al.  Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus , 1991, Molecular and cellular biology.

[3]  I. Verma,et al.  IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family , 1992, Cell.

[4]  S. Ruben,et al.  Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative , 1992, Molecular and cellular biology.

[5]  P. Morin,et al.  The C terminus of the NF-χB p50 precursor and an IχB isoform contain transcription activation domains , 1992 .

[6]  S. Ruben,et al.  Identification of a Naturally Occurring Transforming Variant of the p65 Subunit of NF-KB , 1992, Science.

[7]  M. Fournel,et al.  Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn , 1992, The Journal of experimental medicine.

[8]  R. Lyle,et al.  An alternatively spliced transcript, p65A2, of the gene encoding the p65 subunit of the transcription factor NF-κB , 1994 .

[9]  S. Gerondakis,et al.  Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Gerondakis,et al.  Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription. , 1994, Molecular and cellular biology.

[11]  A. J. Lopez,et al.  Developmental role of transcription factor isoforms generated by alternative splicing. , 1995, Developmental biology.

[12]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[13]  A. Mantovani,et al.  Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist , 1995, The Journal of experimental medicine.

[14]  J. Fargnoli,et al.  Molecular Cloning of Rodent p72Syk. , 1995, The Journal of Biological Chemistry.

[15]  M. Labow,et al.  Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.

[16]  John Calvin Reed,et al.  A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40 , 1995, FEBS letters.

[17]  H. Erdjument-Bromage,et al.  IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.

[18]  D. Goeddel,et al.  TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.

[19]  S. Maxwell,et al.  A novel NF-kappa B p65 spliced transcript lacking exons 6 and 7 in a non-small cell lung carcinoma cell line. , 1995, Gene.

[20]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[21]  D. Goeddel,et al.  Anatomy of TRAF2 , 1996, The Journal of Biological Chemistry.

[22]  D. Baltimore,et al.  Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. , 1996, Immunity.

[23]  G. Fantuzzi,et al.  Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. , 1997, Journal of immunology.

[24]  C. Plata-salamán,et al.  Interleukin‐1β (IL‐1β)‐induced modulation of the hypothalamic IL‐1β system, tumor necrosis factor‐α, and transforming growth factor‐β1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: Implications to IL‐1β feedback systems and cytokine–cytokine interactions , 1997, Journal of neuroscience research.

[25]  Z. Cao,et al.  Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Gascoyne,et al.  Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family. , 1997, Journal of immunology.

[27]  C. Plata-salamán,et al.  Central Nervous System IL-1β System and Neuropeptide Y mRNAs During IL-1β-induced Anorexia in Rats , 1997, Brain Research Bulletin.

[28]  S. Lederman,et al.  A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation. , 1998, Molecular immunology.

[29]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[30]  K. Yanagisawa,et al.  Molecular cloning of human TAK1 and its mutational analysis in human lung cancer , 1998, International journal of cancer.

[31]  G. Cheng,et al.  An Intact Zinc Ring Finger Is Required for Tumor Necrosis Factor Receptor-associated Factor-mediated Nuclear Factor-κB Activation but Is Dispensable for c-Jun N-terminal Kinase Signaling* , 1998, The Journal of Biological Chemistry.

[32]  L. Weissbach,et al.  Detection of an interleukin-1 intracellular receptor antagonist mRNA variant. , 1998, Biochemical and biophysical research communications.

[33]  H. Lodish,et al.  Tumor Necrosis Factor Receptor (TNFR)-associated Factor 2A (TRAF2A), a TRAF2 Splice Variant with an Extended RING Finger Domain That Inhibits TNFR2-mediated NF-κB Activation* , 1998, The Journal of Biological Chemistry.

[34]  H. Sakurai,et al.  TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism. , 1998, Biochemical and biophysical research communications.

[35]  D. Moore,et al.  Alternative Splicing Variants of IκBβ Establish Differential NF-κB Signal Responsiveness in Human Cells , 1998, Molecular and Cellular Biology.

[36]  A. Strasser,et al.  B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells , 1998, The Journal of experimental medicine.

[37]  W. Arend,et al.  The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes. , 1998, Journal of immunology.

[38]  M. Gelfand,et al.  Frequent alternative splicing of human genes. , 1999, Genome research.

[39]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[40]  S. Lederman,et al.  TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation. , 1999, Molecular immunology.

[41]  P. Georgel,et al.  Dorsal-B, a splice variant of the Drosophila factor Dorsal, is a novel Rel/NF-kappaB transcriptional activator. , 1999, Gene.

[42]  A. Whitehead,et al.  IL-1 Signaling Cascade in Liver Cells and the Involvement of a Soluble Form of the IL-1 Receptor Accessory Protein1 2 , 2000, The Journal of Immunology.

[43]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[44]  M. Du,et al.  Screening for mutations of Bcl10 in leukaemia , 2000, British journal of haematology.

[45]  P Bork,et al.  EST comparison indicates 38% of human mRNAs contain possible alternative splice forms , 2000, FEBS letters.

[46]  R. Brink,et al.  Complete structural characterisation of the mammalian and Drosophila TRAF genes: implications for TRAF evolution and the role of RING finger splice variants. , 2000, Molecular immunology.

[47]  H. Sakurai,et al.  Alternative splicing and gene structure of the transforming growth factor beta-activated kinase 1. , 2000, Biochimica et biophysica acta.

[48]  W. Arend,et al.  Biological role of interleukin 1 receptor antagonist isoforms , 2000, Annals of the rheumatic diseases.

[49]  A. Masuda,et al.  Cutting Edge: Naturally Occurring Soluble Form of Mouse Toll-Like Receptor 4 Inhibits Lipopolysaccharide Signaling1 , 2000, The Journal of Immunology.

[50]  W. Gish,et al.  Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. , 2001, Genome research.

[51]  A. Whitehead,et al.  IRAK1b, a Novel Alternative Splice Variant of Interleukin-1 Receptor-associated Kinase (IRAK), Mediates Interleukin-1 Signaling and Has Prolonged Stability* , 2001, The Journal of Biological Chemistry.

[52]  F. Uckun,et al.  Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia , 2001, Oncogene.

[53]  S. Lederman,et al.  Expression and function of TRAF-3 splice-variant isoforms in human lymphoma cell lines. , 2001, Human immunology.

[54]  D. Männel,et al.  A Novel p75TNF Receptor Isoform Mediating NFκB Activation* , 2001, The Journal of Biological Chemistry.

[55]  N. Huh,et al.  PKCθII, a New Isoform of Protein Kinase C Specifically Expressed in the Seminiferous Tubules of Mouse Testis* , 2001, The Journal of Biological Chemistry.

[56]  Christopher J. Lee,et al.  Genome-wide detection of alternative splicing in expressed sequences of human genes , 2001, Nucleic Acids Res..

[57]  T. Muta,et al.  A Novel IκB Protein, IκB-ζ, Induced by Proinflammatory Stimuli, Negatively Regulates Nuclear Factor-κB in the Nuclei* , 2001, The Journal of Biological Chemistry.

[58]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[59]  A. Raikhel,et al.  Characterization of three alternatively spliced isoforms of the Rel/NF-κB transcription factor Relish from the mosquito Aedes aegypti , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  T. Atkinson,et al.  Identification of an alternatively spliced isoform of the fyn tyrosine kinase. , 2002, Biochemical and biophysical research communications.

[61]  J. Tschopp,et al.  Regulation of Interleukin-1- and Lipopolysaccharide-Induced NF-κB Activation by Alternative Splicing of MyD88 , 2002, Current Biology.

[62]  L. Schwarzfischer,et al.  Transcriptional Regulation of the Human Toll-Like Receptor 2 Gene in Monocytes and Macrophages1 , 2002, The Journal of Immunology.

[63]  W. Arend.  The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.

[64]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[65]  T. Kawakami,et al.  Protein Kinase Cβ (PKCβ): Nomal Functions and Dieases , 2002 .

[66]  Dirk E. Smith,et al.  The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. , 2003, Immunity.

[67]  Jiahuai Han,et al.  TAB1β (Transforming Growth Factor-β-activated Protein Kinase 1-binding Protein 1β), a Novel Splicing Variant of TAB1 That Interacts with p38α but Not TAK1* , 2003, The Journal of Biological Chemistry.

[68]  H. Yokosawa,et al.  Regulation of ascidian Rel by its alternative splice variant. , 2003, European journal of biochemistry.

[69]  T. Gilmore,et al.  Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells , 2003, Oncogene.

[70]  W. Arend,et al.  Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways. , 2003, Cytokine.

[71]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[72]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[73]  W. Symmans,et al.  Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. , 2003, Cancer research.

[74]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[75]  A. Whitehead,et al.  Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis. , 2003, Cellular signalling.

[76]  M. Hayakawa,et al.  A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK). , 2003, The Biochemical journal.

[77]  K. Jeang,et al.  Segregation of NF-κB activation through NEMO/IKKγ by Tax and TNFα: implications for stimulus-specific interruption of oncogenic signaling , 2003, Oncogene.

[78]  J. Tschopp,et al.  MyD88S, a splice variant of MyD88, differentially modulates NF‐κB‐ and AP‐1‐dependent gene expression , 2003, FEBS letters.

[79]  D. Kalaitzidis,et al.  The c-Rel transcription factor and B-cell proliferation: a deal with the devil , 2004, Oncogene.

[80]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.

[81]  B. Brinkman,et al.  Splice variants as cancer biomarkers. , 2004, Clinical biochemistry.

[82]  M. Hardy,et al.  The Murine Irak2 Gene Encodes Four Alternatively Spliced Isoforms, Two of Which Are Inhibitory* , 2004, Journal of Biological Chemistry.

[83]  T. Muta,et al.  Positive and Negative Regulation of Nuclear Factor-κB-mediated Transcription by IκB-ζ, an Inducible Nuclear Protein* , 2005, Journal of Biological Chemistry.

[84]  T. Gilmore,et al.  Mutations of tumor necrosis factor α-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability , 2005, Oncogene.

[85]  W. Fung-Leung,et al.  A Novel Splice Variant of Interleukin-1 Receptor (IL-1R)-Associated Kinase 1 Plays a Negative Regulatory Role in Toll/IL-1R-Induced Inflammatory Signaling , 2005, Molecular and Cellular Biology.

[86]  S. Stamm,et al.  Function of Alternative Splicing , 2004 .

[87]  K. Jeang,et al.  An Alternative Splice Product of IκB Kinase (IKKγ), IKKγ-Δ, DifferentiallyMediates Cytokine and Human T-Cell Leukemia Virus Type 1 Tax-Induced NF-κB Activation , 2006, Journal of Virology.

[88]  G. Sledge,et al.  Protein Kinase C- as a Therapeutic Target in Breast Cancer , 2006 .

[89]  G. Courtois,et al.  Mutations in the NF-κB signaling pathway: implications for human disease , 2006, Oncogene.

[90]  N. Perkins.  Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.

[91]  Alimuddin Zumla,et al.  Myobacterium tuberculosis Induces Selective Up-Regulation of TLRs in the Mononuclear Leukocytes of Patients with Active Pulmonary Tuberculosis1 , 2006, The Journal of Immunology.

[92]  S. Ghosh,et al.  NF-κB and the immune response , 2006, Oncogene.

[93]  A. Smahi,et al.  Novel splicing mutation in the NEMO (IKK‐gamma) gene with severe immunodeficiency and heterogeneity of X‐chromosome inactivation , 2006, American journal of medical genetics. Part A.

[94]  S. Dower,et al.  Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway. , 2006, Cytokine.

[95]  D. Greenhalgh,et al.  CD14-dependent modulation of NF-kappaB alternative splicing in the lung after burn injury. , 2006, Gene.

[96]  S. Gerondakis,et al.  Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.

[97]  R. Skotheim,et al.  Alternative splicing in cancer: noise, functional, or systematic? , 2007, The international journal of biochemistry & cell biology.

[98]  P. Galle,et al.  Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD , 2007, The Journal of experimental medicine.

[99]  A. Šedivá,et al.  Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. , 2007, Microbes and infection.

[100]  R. Siebert,et al.  Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity , 2007, Oncogene.

[101]  R. Paus,et al.  Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control , 2007, Bioessays.

[102]  V. Dixit,et al.  Ubiquitin-mediated regulation of TNFR1 signaling. , 2008, Cytokine & growth factor reviews.

[103]  Yu-Chi Chiang,et al.  A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687. , 2008, Molecular immunology.

[104]  Osamu Takeuchi,et al.  Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2 , 2008, Nature Immunology.

[105]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[106]  T. Barth,et al.  Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL , 2008, Oncogene.